Toll-Like Receptor 3 Influences Glucose Homeostasis and β-Cell Insulin Secretion. 2015

Daniela Strodthoff, and Zuheng Ma, and Tina Wirström, and Rona J Strawbridge, and Daniel F J Ketelhuth, and David Engel, and Robert Clarke, and Sture Falkmer, and Anders Hamsten, and Göran K Hansson, and Anneli Björklund, and Anna M Lundberg
Cardiovascular Research Unit, Center for Molecular Medicine, Department of Medicine, Karolinska Institutet, Stockholm, Sweden Metabolism Unit, Department of Medicine, and Department of Endocrinology, Metabolism and Diabetes, Karolinska Institutet at Karolinska University Hospital Huddinge, Karolinska Institutet/AstraZeneca Integrated Cardio Metabolic Center and Center for Innovative Medicine, NOVUM, Stockholm, Sweden daniela.strodthoff@ki.se.

Toll-like receptors (TLRs) have been implicated in the pathogenesis of type 2 diabetes. We examined the function of TLR3 in glucose metabolism and type 2 diabetes-related phenotypes in animals and humans. TLR3 is highly expressed in the pancreas, suggesting that it can influence metabolism. Using a diet-induced obesity model, we show that TLR3-deficient mice had enhanced glycemic control, facilitated by elevated insulin secretion. Despite having high insulin levels, Tlr3(-/-) mice did not experience disturbances in whole-body insulin sensitivity, suggesting that they have a robust metabolic system that manages increased insulin secretion. Increase in insulin secretion was associated with upregulation of islet glucose phosphorylation as well as exocytotic protein VAMP-2 in Tlr3(-/-) islets. TLR3 deficiency also modified the plasma lipid profile, decreasing VLDL levels due to decreased triglyceride biosynthesis. Moreover, a meta-analysis of two healthy human populations showed that a missense single nucleotide polymorphism in TLR3 (encoding L412F) was linked to elevated insulin levels, consistent with our experimental findings. In conclusion, our results increase the understanding of the function of innate receptors in metabolic disorders and implicate TLR3 as a key control system in metabolic regulation.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011110 Polymorphism, Genetic The regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous genotypes. The concept includes differences in genotypes ranging in size from a single nucleotide site (POLYMORPHISM, SINGLE NUCLEOTIDE) to large nucleotide sequences visible at a chromosomal level. Gene Polymorphism,Genetic Polymorphism,Polymorphism (Genetics),Genetic Polymorphisms,Gene Polymorphisms,Polymorphism, Gene,Polymorphisms (Genetics),Polymorphisms, Gene,Polymorphisms, Genetic
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D004041 Dietary Fats Fats present in food, especially in animal products such as meat, meat products, butter, ghee. They are present in lower amounts in nuts, seeds, and avocados. Fats, Dietary,Dietary Fat,Fat, Dietary
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D005951 Glucose Tolerance Test A test to determine the ability of an individual to maintain HOMEOSTASIS of BLOOD GLUCOSE. It includes measuring blood glucose levels in a fasting state, and at prescribed intervals before and after oral glucose intake (75 or 100 g) or intravenous infusion (0.5 g/kg). Intravenous Glucose Tolerance,Intravenous Glucose Tolerance Test,OGTT,Oral Glucose Tolerance,Oral Glucose Tolerance Test,Glucose Tolerance Tests,Glucose Tolerance, Oral

Related Publications

Daniela Strodthoff, and Zuheng Ma, and Tina Wirström, and Rona J Strawbridge, and Daniel F J Ketelhuth, and David Engel, and Robert Clarke, and Sture Falkmer, and Anders Hamsten, and Göran K Hansson, and Anneli Björklund, and Anna M Lundberg
August 2023, Diabetes,
Daniela Strodthoff, and Zuheng Ma, and Tina Wirström, and Rona J Strawbridge, and Daniel F J Ketelhuth, and David Engel, and Robert Clarke, and Sture Falkmer, and Anders Hamsten, and Göran K Hansson, and Anneli Björklund, and Anna M Lundberg
September 2006, Nature immunology,
Daniela Strodthoff, and Zuheng Ma, and Tina Wirström, and Rona J Strawbridge, and Daniel F J Ketelhuth, and David Engel, and Robert Clarke, and Sture Falkmer, and Anders Hamsten, and Göran K Hansson, and Anneli Björklund, and Anna M Lundberg
March 2007, Nature medicine,
Daniela Strodthoff, and Zuheng Ma, and Tina Wirström, and Rona J Strawbridge, and Daniel F J Ketelhuth, and David Engel, and Robert Clarke, and Sture Falkmer, and Anders Hamsten, and Göran K Hansson, and Anneli Björklund, and Anna M Lundberg
March 2007, Proceedings of the National Academy of Sciences of the United States of America,
Daniela Strodthoff, and Zuheng Ma, and Tina Wirström, and Rona J Strawbridge, and Daniel F J Ketelhuth, and David Engel, and Robert Clarke, and Sture Falkmer, and Anders Hamsten, and Göran K Hansson, and Anneli Björklund, and Anna M Lundberg
January 2003, Molecular endocrinology (Baltimore, Md.),
Daniela Strodthoff, and Zuheng Ma, and Tina Wirström, and Rona J Strawbridge, and Daniel F J Ketelhuth, and David Engel, and Robert Clarke, and Sture Falkmer, and Anders Hamsten, and Göran K Hansson, and Anneli Björklund, and Anna M Lundberg
January 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology,
Daniela Strodthoff, and Zuheng Ma, and Tina Wirström, and Rona J Strawbridge, and Daniel F J Ketelhuth, and David Engel, and Robert Clarke, and Sture Falkmer, and Anders Hamsten, and Göran K Hansson, and Anneli Björklund, and Anna M Lundberg
August 1993, The American journal of physiology,
Daniela Strodthoff, and Zuheng Ma, and Tina Wirström, and Rona J Strawbridge, and Daniel F J Ketelhuth, and David Engel, and Robert Clarke, and Sture Falkmer, and Anders Hamsten, and Göran K Hansson, and Anneli Björklund, and Anna M Lundberg
July 2021, Diabetes,
Daniela Strodthoff, and Zuheng Ma, and Tina Wirström, and Rona J Strawbridge, and Daniel F J Ketelhuth, and David Engel, and Robert Clarke, and Sture Falkmer, and Anders Hamsten, and Göran K Hansson, and Anneli Björklund, and Anna M Lundberg
April 2019, Diabetes,
Daniela Strodthoff, and Zuheng Ma, and Tina Wirström, and Rona J Strawbridge, and Daniel F J Ketelhuth, and David Engel, and Robert Clarke, and Sture Falkmer, and Anders Hamsten, and Göran K Hansson, and Anneli Björklund, and Anna M Lundberg
April 2016, Immunity,
Copied contents to your clipboard!